ERIS Lifesciences consolidated net profit rises 17.66% in the March 2022 quarter

Sales rise 9.79% to Rs 301.10 crore

Net profit of ERIS Lifesciences rose 17.66% to Rs 80.30 crore in the quarter ended March 2022 as against Rs 68.25 crore during the previous quarter ended March 2021. Sales rose 9.79% to Rs 301.10 crore in the quarter ended March 2022 as against Rs 274.25 crore during the previous quarter ended March 2021.

For the full year,net profit rose 14.35% to Rs 406.11 crore in the year ended March 2022 as against Rs 355.14 crore during the previous year ended March 2021. Sales rose 11.20% to Rs 1326.17 crore in the year ended March 2022 as against Rs 1192.64 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales301.10274.25 10 1326.171192.64 11 OPM %32.1834.46 -36.5736.10 - PBDT103.7096.19 8 506.90437.48 16 PBT85.3484.73 1 442.20394.50 12 NP80.3068.25 18 406.11355.14 14

Powered by Capital Market - Live News